Alzheimer's Disease and Related Dementias

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/194

encourage image

There's no tags or description

Looks like no tags are added yet.

195 Terms

1
New cards

normal aging

mild age-associated cognitive decline

2
New cards

mild cognitive impairmen

Measurable decreases in memory and mental function, but not severe enough to interfere with daily functioning

3
New cards

dementia

Major neurocognitive disorder associated with reduced cognitive abilities in one or more areas of cognitive functioning severe enough that interferes with daily functioning

4
New cards

dementia

umbrella term

-Alzheimer's Disease

-Vascular Dementia

-Lewy Body Dementia

-Frontotemporal Dementia

-Parkinson's Disease

-Neurodegenerative disorders

-Alcholism

-Mixed Dementia

5
New cards

Alzheimer's Dementia (AD) epidemiology

• 2/3 of dementia cases

• 6-8% of older adults

• Prevalence doubles every 5 years after age 60

6
New cards

Vascular Dementia epidemiology

• 15-20% of cases

• Often co-exists with AD ("Mixed dementia")

7
New cards

Dementia with Lewy Bodies (DLB) epidemiology

second most common cause in ppl over 65

8
New cards

etiology of dementia

Accumulation of proteins or protein aggregates within the brain that interrupt neuron signaling (and/or alteration of neurotransmitters - e.g, decreased acetylcholine) and set off a cascade of events affecting neuronal function and cell death in a disease-specific pattern

9
New cards

alzheimer disease

Accumulation of beta amyloid plaques/oligomers outside neurons and twisted strands of tau neurofibrillary tangles inside the neurons

10
New cards

lewy body and Parkinson dementia etiology

abnormal aggregates (or clumps) of cytoplasmic alpha-synuclein ("Lewy body") in neurons in the cortex

11
New cards

frontotemporal dementia etiology

• Nerve cells in the front and temporal (side) lobes of the brain die and the lobes shrink

• Tau or ubiquitin proteins

12
New cards

vascular dementia etiology

Blood vessels in the brain are damaged due to lack of blood, oxygen or nutrients

13
New cards

General Symptoms of dementia

• Memory loss, getting lost

• Difficulty communicating, repeating words and information

• Inability to learn or remember new information

• Difficulty with planning and organizing

• Poor coordination and motor function

• Personality changes

• Inappropriate behavior

• Paranoia, agitation, hallucinations

14
New cards

-BP control

-physical activity

-cognitive training

-education

-glucose control

-healthy diet

What are the probable protective factors for dementia?

15
New cards

-age

-fam hx

-APOE4 allele

-down syndrome

-head trauma

-fewer yrs of formal education

-vascular risk factors (HTN, hypercholesterolemia, diabetes, obesity)

-social isolation and loneliness

What are the risk factors for dementia?

16
New cards

-sleep

-cognitive training

-maintain hearing

-physical activity

-diet: mediterranean diet

-avoid social isolation

-higher level of education

What are some tips for healthy aging?

17
New cards

no not unless an autopsy is conducted post-mortem

Can you make a definitive dx of the cause and type of dementia?

18
New cards

exclusion

Dementia is a dx of _________

19
New cards

-obtain through hx

-perform cognitive test

-rule out causes of memory impairment which could be reversible (drug induced, B12 deficiency, depression, infection, HIV, neurosyphilis, meningitis, normal pressure hydrocephalus, folic acid deficiency, hypoglycemia, hemorrhage, stroke, etc)

-labs

-biomarkers

-neuroimaging (noncontrast CT head scan, MRI, PET or FDG-PET (radioactive tracers), Amyloid PET rules out hematoma, stroke, hemorrhage, structural lesions

How do you dx dementia?

20
New cards

Alzheimer's biomarker

-plasma p-tau217: phosphorylated form for the tau protein

-CSF profile: AB42 (protein fragment that forms plaques in the brain)

-low AB43/40 ratio, high p-tau, and high total tau (sensitivity and specificity are about 85-90%)

21
New cards

• CBC

• Electrolytes

• BUN/SCr

• Fasting glucose

• Liver function tests

• Folic acid

• Homocysteine/methylmalonic acid

• Urinalysis/Toxicology

• Thyroid function tests

• CSF analysis

• HIV testing

• PRP

• Vitamin B12 level

What are the commonly ordered labs?

22
New cards

Alzheimer's amyloid pathology likely

Plasma p-tau217- sensitivity and specificity 88-89% positive (high value)

23
New cards

confirmation with CSF (lumbar puncture) AB42 or amyloid PET

Plasma p-tau217- sensitivity and specificity 88-89% intermediate

24
New cards

Alzheimer's unlikely

Plasma p-tau217- sensitivity and specificity 88-89% negative (low value)

25
New cards

-Antiemetics (promethazine)

-Antidepressants (especially TCAs)

-Antihistamines/Anticholinergics (diphenhydramine, doxylamine)

-Antipsychotics (chlorpromazine, aripiprazole)

-Barbituates (phenobarbital, butalbital)

-Benzos (alprazolam, clonazepam) and non-BZD hypnotics

-Central anticholinergics (benztropine)

-Peripheral anticholinergics (incontinence and IBS drugs)

-Skeletal muscle relaxants (baclofen)

-other CNS depressants (opioids, sedative hypnotics)

What drugs can worsen dementia?

26
New cards

oxybutynin

anticholinergic often used to treat incontinence

27
New cards

diphenhydramine

anticholinergic often used to treat allergies or insomnia

28
New cards

benztropine, diphenhydramine

anticholinergic often used for dystonic reactions

29
New cards

anticholinergics

Cause acute cognitive impairment

o Occasionally psychosis and hallucinations

o Depends on patients:

-Baseline cognitive function

-Sensitivity to the drug

-Drug clearance

-Number of drugs with additive effects

-Dosing schedule

30
New cards

centrally

You should avoid ________ acting anticholinergics in the elderly

31
New cards

cognitive assessments

-Helpful in diagnosis and monitoring

-Montreal Cognitive Assessment (MoCA)

-Mini-Mental State Exam (MMSE)

-DSM5 criteria

-IADL/ADLS

-used in research (CDR scale)

-used for behaviors (neuropsychiatric inventory quesionnaire)

32
New cards

-language

-education level

-progression of disease

-cognitive domains covered

What are the cognitive assessment selections based on?

33
New cards

Montreal Cognitive Assessment (MoCA)

most sensitive in early disease monitoring and detection

34
New cards

Mini-Mental State Exam (MMSE)

most sensitive in advanced stages (gold standard)

35
New cards

24

A score < ______ on the Mini-Mental State Exam (MMSE) indicates a memory disorder.

36
New cards

IADL/ADLS

more sensitive in monitoring progression

37
New cards

Clinical Dementia Rating (CDR) scale

cognitive assessment used in research

38
New cards

Neuropsychiatric Inventory Questionnaire

cognitive assessment used for behaviors

39
New cards

Mini-Cog

-2 items

-score = 5

-Visuospatial, executive function, recall

40
New cards

St. Louis University Mental Status (SLUMS) Examination

-11 items

-score = 30

-Orientation, recall, calculation,naming, attention, executivefunction

41
New cards

Montreal Cognitive Assessment (MoCA)

-12 items

-score = 30

-Orientation, recall, attention, naming, repetition, verbal fluency,

abstraction, executive function, visuospatial

-Best for identifying early cognitive decline

42
New cards

Folstein Mini-Mental Status Examination (MMSE)

-19 items

-score = 30

-Orientation, registration, attention, recall, naming, repetition, 3-step command, language, visuospatial

-Gold standard - best for monitoring cognitive decline in moderate to severe stages

43
New cards

Functional Activities Questionnaire

-10 items

-score = 30

-Informant based, executive functioning, ADLs, attention, concentration, memory, home safety

44
New cards

Independent Activities of Daily Living

• Using Phones

• Shopping

• Food preparation

• Housekeeping

• Laundry

• Transportation

• Taking medications

• Handling finances

45
New cards

Activities of Daily Living

• Bathing

• Dressing

• Toileting

• Transferring

• Continence

• Feeding

46
New cards

gradual

What is the onset of Alzheimers Disease?

47
New cards

Memory impairment core feature with difficulty learning new information, language, visuospatial

What are the cognitive symptoms of Alzheimers Disease?

48
New cards

rare early, apraxia later

What are the motor symptoms of Alzheimers Disease?

49
New cards

gradual over 8-10 yrs on average

What is the progression of Alzheimers Disease?

50
New cards

possible global atrophy, small hippocampal volumes

What imaging can be done in Alzheimers Disease?

51
New cards

•Amyloid antibodies (MCI/mild)

•Cholinesterase inhibitors (mild-severe)

•Memantine (moderate-severe)

What are the pharmacological txs for Alzheimers Disease?

52
New cards

may be sudden/stepwise

What is the onset of vascular dementia?

53
New cards

depends on anatomy of ischemia, but dysexecutive deficits and slowing common

What are the cognitive symptoms of vascular dementia?

54
New cards

correlates with ischemia

What are the motor symptoms of vascular dementia?

55
New cards

gradual or stepwise with further ischemia

What is the progression of vascular dementia?

56
New cards

cortical or subcortical changes on MRI

What imaging can be done for vascular dementia?

57
New cards

•Cholinesterase inhibitors (for memory deficits only)

•Vascular risk reduction

What are the pharmacological txs for Vascular Dementia?

58
New cards

Gradual (typically presents with visual hallucinations, REM sleep behavior disorder)

What is the onset of dementia with lewy bodies?

59
New cards

memory, visuospatial, hallucinations, fluctuating symptoms

What are the cognitive symptoms of dementia with lewy bodies?

60
New cards

parkinsonism

What are the motor symptoms with dementia with lewy bodies?

61
New cards

gradual, but faster than AD

What is the progression of dementia with lewy bodies?

62
New cards

possible global atrophy

What is the imaging for dementia with lewy bodies?

63
New cards

Cholinesterase inhibitors +/- carbidopa-levodopa for movement

What is the pharmacological tx for dementia with lewy bodies?

64
New cards

gradual, usually < 60

What is the onset of frontrotemporal demenita?

65
New cards

executive, disinhibition, apathy, language, +/- memory

What are the cognitive symptoms of frontrotemporal demenita?

66
New cards

none (rare genetic forms associated with ALS)

What are the motor symptoms with frontrotemporal dementia?

67
New cards

gradual, but faster than AD

What is the progression of frontrotemporal dementia?

68
New cards

atrophy in frontral and temporal lobes

What is the imaging for frontrotemporal dementia?

69
New cards

non recommended with current evidence

What are the pharmacologic txs for frontrotemporal dementia?

70
New cards

Alzheimer's Disease

abnormal deposits of proteins from amyloid plaques and tau tangles throughout the brain

71
New cards

frontotemporal dementia

abnormal amounts or forms of tau and TDP-43 proteins accumulate inside neurons in the frontal and temporal lobes

72
New cards

lewy body dementia

Abnormal deposits of the alpha-synuclein protein, called "Lewy bodies," affect the brain's chemical messengers

73
New cards

vascular dementia

conditions, such as blood clots, disrupt blood flow in the brain

74
New cards

preclinical AD

no symptoms but possible biological changes in the brain

75
New cards

mild cognitive impairment due to AD

very mild symptoms that may not interfere with every day activites

76
New cards

dementia due to AD mild

symptoms interfere with some everyday activities

77
New cards

dementia due to AD moderate

symptoms interfere with many everyday activities

78
New cards

dementia due to AD severe

symptoms interfere with most everyday activities

79
New cards

stage 1 dementia

-No cognitive impairment

-Unimpaired individuals experience no memory problems, and none is evident to a health care professional during a medical

interview.

80
New cards

stage 2 dementia

-Very mild cognitive decline

-Individuals at this stage feel as if they have memory lapses, especially in forgetting familiar words or names or the locatio n of keys, eyeglasses, or other everyday objects. However, these problems are not evident during a medical examination or apparent to friends, family, or coworkers.

81
New cards

stage 3 dementia

-Mild cognitive decline

-Early-stage Alzheimer disease can be diagnosed in some, but not all, individuals with these symptoms.

-Friends, family, or coworkers begin to notice deficiencies. Problems with memory or concentration may be measurable in clinic al testing or discernible during a detailed medical interview. -Common difficulties include the following:

-Word- or name-finding problems noticeable to family or close associates

-Decreased ability to remember names when introduced to new people

-Performance issues in social or work settings noticeable to family, friends, or coworkers

-Reading a passage and retaining little material

-Losing or misplacing a valuable object

-Decline in ability to plan or organize

82
New cards

stage 4 dementia

-Moderate cognitive decline (mild or early-stage Alzheimer disease)

-At this stage, a careful medical interview detects clear-cut deficiencies in the following areas:

-Decreased knowledge of recent occasions or current events

-Impaired ability to perform challenging mental arithmetic, eg, to count backward from 100 by 7s

-Decreased ability to perform complex tasks, such as shopping, planning dinner for guests, or paying bills and managing finances

-Reduced memory of personal history

-The affected individual may seem subdued and withdrawn, especially in socially or mentally challenging situations.

83
New cards

stage 5 dementia

-Moderately severe cognitive decline (moderate or mid-stage Alzheimer disease)

-Major gaps in memory and deficits in cognitive function emerge. Some assistance with day -to-day activities becomes essential. At

this stage, individuals may:

-Be unable during a medical interview to recall such important information as their current address, their telephone number, o r

the name of the college or high school from which they graduated

-Become confused about where they are or about the date, day of the week, or season

-Have trouble with less challenging mental arithmetic, e.g., counting backward from 40 by 4s or from 20 by 2s

-Need help choosing proper clothing for the season or occasion

-Usually retain substantial knowledge about themselves and know their own name and the names of their spouse or children

-Usually require no assistance with eating or using the toilet

84
New cards

stage 6 dementia

-Severe cognitive decline (moderately severe or mid-stage Alzheimer disease)

-Memory difficulties continue to worsen, significant personality changes may emerge, and affected individuals need extensive h elp with customary daily activities. At this stage, individuals may:

-Lose most awareness of recent experiences, events, and surroundings

-Recollect their personal history imperfectly, although they generally recall their own name

-Occasionally forget the name of their spouse or primary caregiver but generally can distinguish familiar from unfamiliar face

-Need help getting dressed properly; without supervision, may make errors such as putting pajamas over daytime clothes or shoes on wrong feet

-Experience disruption of their normal sleep-wake cycle

-Need help with handling details of toileting (flushing toilet, wiping, and disposing of tissue properly)

-Have increasing episodes of urinary or fecal incontinence

-Experience significant personality changes and behavioral symptoms, including suspiciousness and delusions (eg, believing that their caregiver is an impostor); hallucinations (seeing or hearing things that are not really there); or compulsive, repetitive

behaviors such as hand wringing or tissue shredding

-Tend to wander and become lost

85
New cards

stage 7 dementia

-Very severe cognitive decline (severe or late-stage Alzheimer disease)

-This is the final stage of the disease when individuals lose the ability to respond to their environment, to speak, and ultim ately to

control movement.

-Frequently lose the ability for recognizable speech, although words or phrases may occasionally be uttered

-Need help with eating and toileting, and there is general urinary incontinence

-Lose the ability to walk without assistance, then the ability to sit without support, smile, and to hold up head; reflexes be come

abnormal, muscles grow rigid, and swallowing is impaired

86
New cards

• Manage dementia related cognitive, behavioral, and psychosocial issues

• Enhance quality of life and maximize functional performance by improving or stabilizing cognition, mood, and behavior

• Recognize acute changes and factors that contribute to behavioral changes

What are the goals of tx in dementia?

87
New cards

non-pharm tx of dementia

• Cognitive Training

• Supportive individual and group therapy

• Physical and mental activity

• Family and caregiver education and support

• Safety monitoring

o ADL/IADL oversight, wandering, driving, etc

• Environmental modifications

o Supportive strategies such as clocks, calendars, to-do lists, visual clues, simple and compassionate communication styles

o Structure activities to match patient abilities

88
New cards

• Vitamin E 2,000 IU daily - inconsistent findings

• Ginkgo Biloba - increases risk of bleeding

• Apoaequorin (Prevagen) - increases risk of stroke

• Coral calcium

• Coenzyme Q10

• Phosphatidylserine

What are the natural products "used for dementia" but should be avoided and are NOT recommended?

89
New cards

Amyloid-beta antibodies

o Lecanemab (Leqembi)

o Donanemab (Kinsula)

90
New cards

Leqembi

Lecanemab

91
New cards

Kinsula

Donanemab

92
New cards

Acetylcholinesterase inhibitors

o Donepezil (Aricept)

o Galantamine (Razadyne)

o Rivastigmine (Exelon)

93
New cards

Aricept

donepezil

94
New cards

Razadyne

galantamine

95
New cards

Exelon

rivastigmine

96
New cards

Namena

memantine

97
New cards

Namzaric

donepezil + memantine

98
New cards

NMDA receptor blocker

Memantine (Namenda)

99
New cards

symptom

Acetylcholinesterase inhibitors and NMDA receptor blockers do ___________ management.

- Does not reverse dementia

- May delay progression

- Might modestly delay cognitive decline, delay onset of behaviors, maintain ADLs longer

100
New cards

reduction in beta amyloid plaque distribution on PET imaging, but

clinical correlation in delay in disease progression appears to limited to those in the very early stages of disease. Significant

side effects and cost.

Why are amyloid-beta antibodies controversial?